Home
News
All News
Brain mapping effort searches for roots of Parkinson’s and other diseases
Back To All News
Allen Institute initiative aims to capture earliest cellular changes and identify new drug targets
Allen Institute launched Brain Health accelerator ($200M) mapping pre-pathology cells in Parkinson's, Huntington, ALS with AI analysis. Cross-species cell mapping reduces preclinical drug risk, enabling targeted interventions and human trials within 5 years.
Home
News
All News
Brain mapping effort searches for roots of Parkinson’s and other diseases
Back To All News

The Allen Institute is launching a $200 million initiative to explore specific neurodegenerative diseases and even develop drugs…

The Allen Institute in Seattle says scientists have now learned enough about how the brain works to start fixing it when it…

News and commentary from the world of neurology and neuroscience

Stay up to date with notifications from The IndependentNotifications can be managed in browser preferences.Jump to contentThank…

Researchers are increasingly using AI to accelerate the search for treatments for neurological conditions such as Alzheimers,…

Groundbreaking brain atlases reveal dynamic neuron and glia development across species, transforming static maps into a living…

AI-Powered drug discovery could transform treatment development for Alzheimer’s, Parkinson’s and other brain disorders.